News and Press Releases
About the CF Foundation | Antibiotics | Infection Prevention and Control CF Foundation Invests Up to $4.85 Million in Aridis Pharmaceuticals for Testing of Anti-Infective

The investment will go toward finishing a Phase 2a clinical trial for an anti-infective to treat chronic infections in people with CF.

| 2 min read
About the CF Foundation Cystic Fibrosis Foundation Announces Irena Barisic as Next Chief Operating and Financial Officer

Barisic will transition from current role as Chief Financial and Administrative Officer in January 2023

| 3 min read
About the CF Foundation | Our Research Approach CF Foundation Provides Additional Funding to Carmine Therapeutics for Early-Stage Research Into Potential Genetic Therapy

The Cystic Fibrosis Foundation is providing up to $5 million to develop a method to deliver a healthy copy of the CFTR gene into the lung cells of people with CF that is unlikely to trigger an immune system response.

| 4 min read
About the CF Foundation | Diagnosis CF Foundation Continues Working Toward Equity and Timeliness in Cystic Fibrosis Newborn Screening

Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.

| 3 min read
About the CF Foundation | Diversity, Equity, and Inclusion CF Foundation Joins More Than 2,000 CEOs in Commitment to Advance Diversity and Inclusion in the Workplace

CEO pledge is part of the Foundation’s ongoing commitment to strengthen the organization and better serve all people with CF

| 3 min read
About the CF Foundation | Care Centers Journal of Cystic Fibrosis Spotlights the Evolving Cystic Fibrosis Care Model

The cystic fibrosis care model is evolving to support people living longer with CF and their increasingly diverse health needs. Catalyzed by the approval of Trikafta® and the COVID-19 pandemic, this adaptive and personalized care model encompasses novel ways to connect clinicians and patients.

| 4 min read
About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Invests $6M in Carbon Biosciences to Advance New Gene Therapy Approach for Cystic Fibrosis

Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to work alongside CF Foundation researchers at the Foundation’s therapeutics lab

| 4 min read
About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Invests $5 Million in Sionna Therapeutics to Develop New CFTR Modulator Therapy

New modulators in development by the CF-specific company could provide unique treatment options for the underlying cause of cystic fibrosis for many people with the disease

| 3 min read
About the CF Foundation | Researcher Resources Cystic Fibrosis Foundation Launches Inaugural Golden Ticket Competition to Find the Next Genetic Therapies for CF

Early stage researchers, life science entrepreneurs, and companies are encouraged to apply starting May 2

| 6 min read
About the CF Foundation | Advocacy CF Foundation Announces New National Advocacy Chairs

Marissa Benchea and Jeremy and Rachel Olimb to lead the Foundation’s volunteer advocacy base into a new chapter of CF

| 5 min read